Endo International plc
NASDAQ: ENDP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Blaise Coleman
- Employees
- 3,103
- Headquarters
- Dublin, United States
- IPO year
- 2014
- Website
- https://www.endo.com
Loading ENDP…
Loading profile data…Frequently asked questions about ENDP
What does Endo International plc (ENDP) do?
Endo International plc operates as a specialty pharmaceutical firm, developing and marketing both proprietary brand-name and unbranded generic medications across the United States and global markets. Its Branded Pharmaceuticals division offers a diverse array of prescription products, notably including XIAFLEX for the treatment of Dupuytren's co...
Where does ENDP trade?
Endo International plc (ENDP) trades on the NASDAQ Global Select.
What sector is ENDP in?
Endo International plc (ENDP) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Endo International plc?
Blaise Coleman is the chief executive officer of Endo International plc (ENDP).
Where is Endo International plc headquartered?
Endo International plc is headquartered in United States.
Does ENDP pay a dividend?
Endo International plc (ENDP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENDP go public?
Endo International plc (ENDP) completed its initial public offering in 2014.